Robert Roskoski
Impact in
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Molecular Biology top 0.2%
- Protein Kinase Regulation and GTPase Signaling
- PI3K/AKT/mTOR signaling in cancer
- Melanoma and MAPK Pathways
Papers in
- Biochemistry 13
- Amino Acid Enzymes and Metabolism 11
- Genetics 18
- Chronic Lymphocytic Leukemia Research 14
- Co-authors
- Kent E. VranaFabian HartlFritz LipmannHorst KleinkaufPaul CookDeepak BhatnagarWieland GeversPhillip G. Schmid
- Journals
- Pharmacological Research (47 papers)Biochemistry (21 papers)Biochemical and Biophysical Research Communications (16 papers)Journal of Neurochemistry (14 papers)Archives of Biochemistry and Biophysics (6 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Robert Roskoski
167 papers receiving 14.8k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Oncology 4.1k
- Molecular Biology 9.9k
- Genetics 1.1k
- Cancer Research 1.4k
- Cell Biology 1.3k
Countries citing papers authored by Robert Roskoski
This map shows the geographic impact of Robert Roskoski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Roskoski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Roskoski more than expected).
Fields of papers citing papers by Robert Roskoski
This network shows the impact of papers produced by Robert Roskoski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Roskoski. The network helps show where Robert Roskoski may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Roskoski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | Properties of FDA-approved small molecule protein kinase inhibitors: A 2025 update Hit paper breakdown → | 2025 | 15 |
| 6 | 2023 | 17 | |
| 7 | 2023 | 12 | |
| 8 | 2021 | 50 | |
| 9 | 2020 | 17 | |
| 10 | Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update Hit paper breakdown → | 2019 | 424 |
| 11 | 2017 | 109 | |
| 12 | 2016 | 86 | |
| 13 | Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes Hit paper breakdown → | 2015 | 620 |
| 14 | 2014 | 175 | |
| 15 | 2007 | 345 | |
| 16 | 2004 | 309 | |
| 17 | 2004 | 456 | |
| 18 | 1998 | 144 | |
| 19 | 1991 | 10 | |
| 20 | 1988 | 3 |
About Robert Roskoski
Robert Roskoski is a scholar working on Biochemistry, Genetics, Molecular Biology, Clinical Biochemistry and Oncology, having authored 173 papers that have together received 16.3k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (20 papers), Protein Kinase Regulation and GTPase Signaling (19 papers), Biochemical and Molecular Research (16 papers), Chronic Lymphocytic Leukemia Research (14 papers), Melanoma and MAPK Pathways (13 papers), Neuroscience and Neuropharmacology Research (13 papers), Ion channel regulation and function (12 papers) and Amino Acid Enzymes and Metabolism (11 papers). The work is most often cited by research in Oncology (4.1k citations), Molecular Biology (9.9k citations), Genetics (1.1k citations), Cancer Research (1.4k citations) and Cell Biology (1.3k citations). Robert Roskoski has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Kent E. Vrana, Fabian Hartl, Fritz Lipmann, Horst Kleinkauf, Paul Cook, Deepak Bhatnagar, Wieland Gevers, Phillip G. Schmid, Abdollah Sadeghi‐Nejad and Alan H. Stokes. Their work appears in journals such as Pharmacological Research, Biochemistry, Biochemical and Biophysical Research Communications, Journal of Neurochemistry and Archives of Biochemistry and Biophysics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.